Your browser doesn't support javascript.
loading
Humanization of the Prostate Microenvironment Reduces Homing of PC3 Prostate Cancer Cells to Human Tissue-Engineered Bone.
McGovern, Jacqui A; Shafiee, Abbas; Wagner, Ferdinand; Lahr, Christoph A; Landgraf, Marietta; Meinert, Christoph; Williams, Elizabeth D; Russell, Pamela J; Clements, Judith A; Loessner, Daniela; Holzapfel, Boris M; Risbridger, Gail P; Hutmacher, Dietmar W.
Affiliation
  • McGovern JA; Centre in Regenerative Medicine, Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), 60 Musk Avenue, Kelvin Grove, Brisbane, QLD 4059, Australia. jacqui.mcgovern@qut.edu.au.
  • Shafiee A; Centre in Regenerative Medicine, Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), 60 Musk Avenue, Kelvin Grove, Brisbane, QLD 4059, Australia. a.shafiee@qut.edu.au.
  • Wagner F; The University of Queensland (UQ), Diamantina Institute, Translational Research Institute, Brisbane, QLD 4102, Australia. a.shafiee@qut.edu.au.
  • Lahr CA; Centre in Regenerative Medicine, Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), 60 Musk Avenue, Kelvin Grove, Brisbane, QLD 4059, Australia. ferdinand.wagner@med.uni-muenchen.de.
  • Landgraf M; Department of Pediatric Surgery, Dr. von Hauner Children's Hospital, Ludwig-Maximilians-University of Munich, Lindwurmstraße 4, 80337 Munich, Germany. ferdinand.wagner@med.uni-muenchen.de.
  • Meinert C; Centre in Regenerative Medicine, Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), 60 Musk Avenue, Kelvin Grove, Brisbane, QLD 4059, Australia. christoph.lahr@hdr.qut.edu.au.
  • Williams ED; Centre in Regenerative Medicine, Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), 60 Musk Avenue, Kelvin Grove, Brisbane, QLD 4059, Australia. marietta.landgraf@qut.edu.au.
  • Russell PJ; Centre in Regenerative Medicine, Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), 60 Musk Avenue, Kelvin Grove, Brisbane, QLD 4059, Australia. christoph.meinert@qut.edu.au.
  • Clements JA; Australian Prostate Cancer Research Centre-Queensland, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology, Princess Alexandra Hospital, Translational Research Institute, Brisbane, QLD 4102, Australia. ed.williams@qut.edu.au.
  • Loessner D; Australian Prostate Cancer Research Centre-Queensland, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology, Princess Alexandra Hospital, Translational Research Institute, Brisbane, QLD 4102, Australia. pamela.russell@qut.edu.au.
  • Holzapfel BM; Australian Prostate Cancer Research Centre-Queensland, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology, Princess Alexandra Hospital, Translational Research Institute, Brisbane, QLD 4102, Australia. j.clements@qut.edu.au.
  • Risbridger GP; Centre in Regenerative Medicine, Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), 60 Musk Avenue, Kelvin Grove, Brisbane, QLD 4059, Australia. daniela.lossner@qut.edu.au.
  • Hutmacher DW; Centre for Cancer and Inflammation, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK. daniela.lossner@qut.edu.au.
Cancers (Basel) ; 10(11)2018 Nov 13.
Article de En | MEDLINE | ID: mdl-30428629

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Cancers (Basel) Année: 2018 Type de document: Article Pays d'affiliation: Australie Pays de publication: Suisse

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Cancers (Basel) Année: 2018 Type de document: Article Pays d'affiliation: Australie Pays de publication: Suisse